EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest

Anouk Sesink, Margaux Becerra, Jia-Ling Ruan, Sophie Leboucher, Maxime Dubail, Sophie Heinrich, Wael Jdey, Kristoffer Petersson, Charles Fouillade, Nathalie Berthault, Marie Dutreix iD, Pierre-Marie Girard iD

NAR Cancer · 09.01.2024 · 6 (1)

DOI: 10.1093/narcan/zcae011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 12.03.2024. Verfasst von Anouk Sesink und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, Université PSL, CNRS UMR3347, INSERM U1021, 91405 Orsay, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Radiation-Protective Agents, DNA Breaks, Double-Stranded, G1 Phase Cell Cycle Checkpoints. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, European Union's Framework Program, Research and Innovation Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AsiDNA™, a cholesterol-coupled oligonucleotide mimicking double-stranded DNA breaks, was developed to sensitize tumour cells to radio- and chemotherapy. This drug acts as a decoy hijacking the DNA damage response. Previous studies have demonstrated that standalone AsiDNA™ administration is well tolerated with no additional adverse effects when combined with chemo- and/or radiotherapy. The lack of normal tissue complication encouraged further examination into the role of AsiDNA™ in normal cells. This research demonstrates the radioprotective properties of AsiDNA™. In vitro, AsiDNA™ induces a DNA-PK/p53/p21-dependent G1/S arrest in normal epithelial cells and fibroblasts that is absent in p53 deficient and proficient tumour cells. This cell cycle arrest improved survival after irradiation only in p53 proficient normal cells. Combined administration of AsiDNA™ with conventional radiotherapy in mouse models of late and early radiation toxicity resulted in decreased onset of lung fibrosis and increased intestinal crypt survival. Similar results were observed following FLASH radiotherapy in standalone or combined with AsiDNA™. Mechanisms comparable to those identified in vitro were detected both in vivo, in the intestine and ex vivo, in precision cut lung slices. Collectively, the results suggest that AsiDNA™ can partially protect healthy tissues from radiation toxicity by triggering a G1/S arrest in normal cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Radiation-Protective AgentsDNA Breaks, Double-StrandedG1 Phase Cell Cycle CheckpointsOligonucleotidesAnimalsMiceDNA-Activated Protein KinaseHumansCyclin-Dependent Kinase Inhibitor p21

Substanzen

Tumor Suppressor Protein p53DNA-Activated Protein KinaseRadiation-Protective AgentsCyclin-Dependent Kinase Inhibitor p21Oligonucleotides

Autor:innen und Institutionen

  • Institut Curie, Université PSL, CNRS UMR3347, INSERM U1021, 91405 Orsay, France.
  • Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, 91405 Orsay, France.
  • Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK.
  • Histology platform, Institut Curie, CNRS UMR3348, 91405 Orsay, France.
  • Valerio Therapeutics, 49 Bd du Général Martial Valin, 75015 Paris, France.
  • Radiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.

ORCID-Profile: Marie Dutreix, Pierre-Marie Girard

Förderung

  • Medical Research Council
  • European Union's Framework Program
  • Research and Innovation Horizon 2020
  • ITN THERADNET
  • Marie Skłodowska-Curie
  • Valerio Therapeutics
  • S.I.T. Sordina IORT Technologies S.p.A.
  • Fondation pour la Recherche sur le Cancer

Zitieren

APA

Sesink, A., Becerra, M., Ruan, J. L., Leboucher, S., Dubail, M., Heinrich, S., Jdey, W., Petersson, K., Fouillade, C., Berthault, N., Dutreix, M., & Girard, P. M. (2024). The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest. NAR Cancer, 6(1). https://doi.org/10.1093/narcan/zcae011

Vancouver

Sesink A, Becerra M, Ruan JL, Leboucher S, Dubail M, Heinrich S, et al. The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest. NAR Cancer. 2024;6(1). doi:10.1093/narcan/zcae011

BibTeX
@article{Sesink2024,
  author = {Sesink, Anouk and Becerra, Margaux and Ruan, Jia-Ling and Leboucher, Sophie and Dubail, Maxime and Heinrich, Sophie and Jdey, Wael and Petersson, Kristoffer and Fouillade, Charles and Berthault, Nathalie and Dutreix, Marie and Girard, Pierre-Marie},
  title = {The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest},
  journal = {NAR Cancer},
  year = {2024},
  volume = {6},
  number = {1},
  doi = {10.1093/narcan/zcae011}
}
Kostenlos starten →